PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
16362659 | HLA (HLA) | migraine | Italian | NA | NA | unclassified | |
our data suggest the presence of a genetic susceptibility factor for migraine within the hla region. | |||||||
19253056 | HLA (HLA) | migraine without aura | Sardinian | NA | NA | unclassified | |
these data suggest that subjects with the tnfb2 allele have a low risk of developing migraine without aura and/or that the polymorphism of the tnf-beta gene is in linkage disequilibrium with other migraine responsible genes in the hla region. | |||||||
23508008 | HLA-A*02 | mantle cell lymphoma | NA | NA | NA | unclassified | |
mantle cell lymphoma-reactive t-cell lines from hla-a*0201(+) healthy blood donors were generated after in vitro restimulation, and were subjected to functional tests. | |||||||
9698100 | MHC (MHC) | intestinal schistosomiasis | NA | NA | NA | unclassified | |
down modulation of mhc surface molecules on b cells by suppressive immune complexes obtained from chronic intestinal schistosomiasis patients. | |||||||
9704769 | HLA-DR (HLA-DR) | preeclampsias | NA | NA | NA | unclassified | |
our aim was to seek evidence for circulating leukocyte activation in preeclampsia.study designwhole blood flow cytometric techniques were used to analyze surface markers of activation (cd11b, cd14, cd23, cd49d, cd62l, cd64, cd66b, hla-dr) and intracellular reactive oxygen species. | |||||||
10867793 | NA (NA) | infarction | NA | prostaglandin | NA | unclassified | |
co-expression of the activation antigens hla-dr, -dp, -dq (mhc class ii) or the macrophage inhibitor factor-related protein mrp-8 (s100a8) by most cox-1+ microglia/macrophages was only seen early after infarction. | |||||||
10867793 | DP (HAPLOTYPE) | infarction | NA | prostaglandin | NA | unclassified | |
co-expression of the activation antigens hla-dr, -dp, -dq (mhc class ii) or the macrophage inhibitor factor-related protein mrp-8 (s100a8) by most cox-1+ microglia/macrophages was only seen early after infarction. | |||||||
10867793 | HLA-DR (HLA-DR) | infarction | NA | prostaglandin | NA | unclassified | |
co-expression of the activation antigens hla-dr, -dp, -dq (mhc class ii) or the macrophage inhibitor factor-related protein mrp-8 (s100a8) by most cox-1+ microglia/macrophages was only seen early after infarction. | |||||||
27086038 | HLA (HLA) | melioidosis | NA | epitopic | NA | only_studied | |
identification of cd4+ t-cell epitope and investigation of hla distribution for the immunogenic proteins of burkholderia pseudomallei using in silico approaches - a key vaccine development strategy for melioidosis. | |||||||
19139173 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | drug hypersensitivity | NA | NA | NA | unclassified | |
human leukocyte antigen (hla) gene polymorphism plays a critical role in protective immunity, disease susceptibility, autoimmunity, and drug hypersensitivity, yet the basis of how hla polymorphism influences t cell receptor (tcr) recognition is unclear. |
Copyright 2024